BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 31519186)

  • 1. Iron and leukemia: new insights for future treatments.
    Wang F; Lv H; Zhao B; Zhou L; Wang S; Luo J; Liu J; Shang P
    J Exp Clin Cancer Res; 2019 Sep; 38(1):406. PubMed ID: 31519186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron metabolism: an emerging therapeutic target underlying the anti-cancer effect of quercetin.
    Yin M; Liu Y; Chen Y
    Free Radic Res; 2021 Mar; 55(3):296-303. PubMed ID: 33818251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells.
    Grignano E; Birsen R; Chapuis N; Bouscary D
    Front Oncol; 2020; 10():586530. PubMed ID: 33042852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic regulation of the bone marrow microenvironment in leukemia.
    Xu B; Hu R; Liang Z; Chen T; Chen J; Hu Y; Jiang Y; Li Y
    Blood Rev; 2021 Jul; 48():100786. PubMed ID: 33353770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron as a Central Player and Promising Target in Cancer Progression.
    Jung M; Mertens C; Tomat E; Brüne B
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer.
    Zhou L; Zhao B; Zhang L; Wang S; Dong D; Lv H; Shang P
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29789480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic dependencies and vulnerabilities in leukemia.
    Rashkovan M; Ferrando A
    Genes Dev; 2019 Nov; 33(21-22):1460-1474. PubMed ID: 31676734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.
    Fanzani A; Poli M
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28783123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies.
    Zhang H; Sun C; Sun Q; Li Y; Zhou C; Sun C
    Front Mol Biosci; 2023; 10():1275774. PubMed ID: 37818101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells.
    El Hout M; Dos Santos L; Hamaï A; Mehrpour M
    Semin Cancer Biol; 2018 Dec; 53():125-138. PubMed ID: 30071257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IdeR, a DtxR Family Iron Response Regulator, Controls Iron Homeostasis, Morphological Differentiation, Secondary Metabolism, and the Oxidative Stress Response in Streptomyces avermitilis.
    Cheng Y; Yang R; Lyu M; Wang S; Liu X; Wen Y; Song Y; Li J; Chen Z
    Appl Environ Microbiol; 2018 Nov; 84(22):. PubMed ID: 30194099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.
    Valko M; Jomova K; Rhodes CJ; Kuča K; Musílek K
    Arch Toxicol; 2016 Jan; 90(1):1-37. PubMed ID: 26343967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of oxidative stress in the metabolic syndrome.
    Whaley-Connell A; McCullough PA; Sowers JR
    Rev Cardiovasc Med; 2011; 12(1):21-9. PubMed ID: 21546885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanolongan with Multiple On-Demand Conversions for Ferroptosis-Apoptosis Combined Anticancer Therapy.
    Bao W; Liu X; Lv Y; Lu GH; Li F; Zhang F; Liu B; Li D; Wei W; Li Y
    ACS Nano; 2019 Jan; 13(1):260-273. PubMed ID: 30616348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cells with irons in the fire.
    Bystrom LM; Rivella S
    Free Radic Biol Med; 2015 Feb; 79():337-42. PubMed ID: 24835768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.
    Potůčková E; Roh J; Macháček M; Sahni S; Stariat J; Šesták V; Jansová H; Hašková P; Jirkovská A; Vávrová K; Kovaříková P; Kalinowski DS; Richardson DR; Šimůnek T
    PLoS One; 2015; 10(10):e0139929. PubMed ID: 26460540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in normal hematopoietic stem cells and leukemia.
    Samimi A; Kalantari H; Lorestani MZ; Shirzad R; Saki N
    APMIS; 2018 Apr; 126(4):284-294. PubMed ID: 29575200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autophagy and iron homeostasis].
    Hamaï A; Mehrpour M
    Med Sci (Paris); 2017 Mar; 33(3):260-267. PubMed ID: 28367812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS homeostasis and metabolism: a critical liaison for cancer therapy.
    Kim J; Kim J; Bae JS
    Exp Mol Med; 2016 Nov; 48(11):e269. PubMed ID: 27811934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.